NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/26/2025
Back to search
Official data from USPTO
HAEMATOKINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HAEMATOKINE
ST13
US500000079313038Class
1, 5
Filing
79313038
Registration
6823077
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
09/27/2025
Trademark type
Word
Nice classes
1, 5
Filing date
02/05/2021
Registration date
08/23/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
09/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FI
Examiner
STADELI,MARTA ANN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Faron Pharmaceuticals Oy
Representatives
Mark E. Olds Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; Biological preparations for use in industry and science; Media for cell culture for use in the biotechnological industrycell culture media for scientific and research use; Media for cell culture for use in non-medical research laboratoriescell culture media for laboratory use; Biological preparation for use in cell cultures other than for medical or veterinary use; Culture media for microbiologyfor scientific and research use; Cell growth media for growing cells for scientific use; Biological preparation for use in cell culturesother than for medical or veterinary use; Cultures of cell media other than for medical or veterinary usenamely culture media for scientific and research use; Cultures of microorganismsother than for medical and veterinary use; Blood culture media being cell culture media for scientific use; Biological preparations for use in cell culturesother than for medical or veterinary purposes; Stem cellsother than for medical or veterinary purposes; Stem cells for scientific purposes; Stem cells for research purposes
Class 5
Pharmaceuticalsmedical and veterinary preparations for the treatment of hematological malignanciesbone marrow dysfunction or suppressions; Sanitary preparations for medical purposes; Stem cells for medical or veterinary use; Stem cells for medical purposes; Tumor suppressing agents; Pharmaceutical preparationsantineoplastics; Anti-neoplastic preparations of chemical originpharmaceutical preparations for hematological malignanciesbone marrow dysfunction or suppressions; Anti-neoplastic preparations of microbial originpharmaceutical preparations for hematological malignanciesbone marrow dysfunction or suppressions; Anti-cancer preparations; Compounds for treating canceranti-cancer preparations; Antibodies for medical purposes for the treatment of hematological malignanciesbone marrow dysfunction or suppressions; Antibodies for medical use to treat inflammation and cancer growth and spread; Adjuvants for medical purposes; Vaccine adjuvants; Biological adjuvants for medical purposes; Anti-inflammatories; Antigenstumour antigens for medical diagnostic purposes; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical usebiological preparations for the treatment of conditions associated with poor production of hematopoietic stem cells; Culture media for medical useculture media for use in augmentation of blood cellsbone marrow and tissues for medical purposes; Media for bacteriological cultures; Cell growth media for growing cells for medical use; Biological preparations for medical purposesbiological preparations for the treatment of hematological malignanciesbone marrow dysfunction or suppressions; Mixed biological preparations for medical purposesmixed biological preparations for the prevention and treatment of infectious diseases; Biological preparations for veterinary purposesbiological preparations for the treatment of hematological malignanciesbone marrow dysfunction or suppressions; Pharmaceutical preparationsimmunomodulators; Immunostimulants; Injectable pharmaceuticals for treatment of hematological malignanciesbone marrow dysfunction or suppressions; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances with anti-inflammatory properties for treatment of hematological malignanciesbone marrow dysfunction or suppressions; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of disorders caused by bacteria; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical products for the treatment of bone diseases; Regulatory proteins for medical useprotein arrays for medical diagnosis purposes; Serotherapeutic medicinespharmaceutical preparations for the treatment of hematological malignanciesbone marrow dysfunction or suppressions; Synthetic peptides for pharmaceutical purposes for the treatment of hematological malignanciesbone marrow dysfunction or suppressions; Pharmaceutical products for treating respiratory diseases; Pharmaceutical compounds for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases; Pharmaceutical compounds for treating correlated pulmonary syndromes; Pharmaceutical preparations for treatment and prevention of ischemic conditionsinflammation and organ damages resulting from tissue traumasreperfusion injuriescancercancer metastasisinflammatory conditions and allergic conditions; Pharmaceutical preparations for treatment and prevention of multi-organ failureacute lung injury and acute respiratory distress syndrome in adultsadolescentschildreninfants and neonates
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/01/2022
FIMP
FINAL DISPOSITION PROCESSED
12/01/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/23/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/23/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2022
PUBO
PUBLISHED FOR OPPOSITION
06/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/29/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/16/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/30/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/30/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/30/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/18/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/18/2022
RFNT
REFUSAL PROCESSED BY IB
10/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2021
RFRR
REFUSAL PROCESSED BY MPU
09/27/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2021
CNRT
NON-FINAL ACTION WRITTEN
09/08/2021
DOCK
ASSIGNED TO EXAMINER
08/30/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/10/2021
Continuous trademark protection
Get notified about every new filing that threatens HAEMATOKINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.